Esperion Therapeutics (United States)

Esperion Therapeutics (United States)

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Esperion Therapeutics (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

52%


Total
Publications

157


Total Open
Publications

82


Total
Citations

9.7K


Open Access
Percentage

52%


Total
Publications

157


Total Open
Publications

82


Total
Citations

9.7K

Wikipedia

Website

download

Breakdown

22% 23% 7% 48%

Publisher Open

22%

Both

23%

Other Platform Open

7%

Closed

48%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

20%OA Journal

OA Journal 20%

14

Hybrid 60%

43

No Guarantees 20%

14

Other Platform Open

Domain 75%

36

Other Internet 21%

10

Institution 17%

8

Preprint 6%

3

Public 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
36
Europe PMC
Domain
20
DOI
Other Internet
4
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
2
medRxiv
Preprint
2
Imperial College London - Spiral
Institution
2
HAL
Other Internet
2
Washington University School of Medicine - Digital Commons@Becker
Institution
1
UWA - UWA Profiles and Research Repository
Other Internet
1
Unknown Repository
Other Internet
1
1 / 2

Data updated 13 May 2024

Share

Share

Share